Skip to content

A real-world study of Shenshao Guipi Decoction in the treatment of ischemic stroke convalescent patients

A real-world study of Shenshao Guipi Decoction in the treatment of ischemic stroke convalescent patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000544
Enrollment
Unknown
Registered
2025-03-18
Start date
2025-07-03
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ischemic stroke

Interventions

Experimental group:Shenshao Guipi Decoction + Basic prevention regimen. Basic prevention regimen refers to the secondary prevention regimen of the Chinese Guidelines for Secondary Prevention of Ischem
Control group:Basic prevention regimen: refer to the secondary prevention regimen of the Chinese Guidelines for Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack 2022, including: a

Sponsors

Shanghai Yueyang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria of ischemic stroke and be diagnosed by cranial MRI; (2) Meet the TCM diagnostic criteria for meridians in ischemic stroke (stroke); (3) Patients in the recovery period of ischemic stroke the course of the disease is within 6 months (= 6 months); (4) Gender is not limited age = 40 years old and = 80 years old; (5) daily activity dependence score mRS=3; (6) Voluntarily agree to participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Those who have serious heart liver kidney and hematopoietic system diseases advanced malignant tumors mental diseases dementia and cannot cooperate with the researcher; (2) Patients with intracranial hemorrhage; (3) mRS > 1 point before the onset of stroke; (4) pregnant or lactating women; (5) Those who are participating in other clinical trials or have participated in the past 3 months (6) Those who have a history of allergies contraindications or intolerance to the main components of ginseng peony guipi drink.

Design outcomes

Primary

MeasureTime frame
Recurrence rate of cerebrovascular events;

Secondary

MeasureTime frame
Emotional assessment;Neurological function;Risk factors for stroke;Sleep status;blood sugar;disability form;Hcy;blood lipids;Cognitive level;TCM syndrome points for stroke;Somatization symptoms;State of fatigue;

Countries

China

Contacts

Public ContactZhang Yunyun

Shanghai Yueyang Hospital

zhangyyshyy@shutcm.edu.cn+86 138 1613 4690

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026